drugset / Trial / NCT00092144

Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)

NCT00092144

Phase 3 Completed 500 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of an approved drug on asthma symptoms in patients with chronic asthma which is also active during the allergy season.

Timeline

Start
2004-02-26
Primary completion
2004-06-15
Completion
2004-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified Oral

Indications